bethanidine has been researched along with Vertigo in 1 studies
Bethanidine: A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Proctor, JD | 1 |
| Evans, EF | 1 |
| Wasserman, AJ | 1 |
1 trial available for bethanidine and Vertigo
| Article | Year |
|---|---|
Comparison of bethanidine dosing schedules for rapid control of blood pressure.
Topics: Adult; Aged; Bethanidine; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Sche | 1976 |